240 related articles for article (PubMed ID: 37349668)
1. Systemic lupus erythematosus associated with development of macrophage activation syndrome and disseminated aspergillosis.
Phoophiboon V; Brown P; Burns KEA
Can J Anaesth; 2023 Jul; 70(7):1255-1260. PubMed ID: 37349668
[TBL] [Abstract][Full Text] [Related]
2. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
5. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
[TBL] [Abstract][Full Text] [Related]
7. Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus.
Borgia RE; Gerstein M; Levy DM; Silverman ED; Hiraki LT
Arthritis Rheumatol; 2018 Apr; 70(4):616-624. PubMed ID: 29342508
[TBL] [Abstract][Full Text] [Related]
8. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
[No Abstract] [Full Text] [Related]
9. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
[TBL] [Abstract][Full Text] [Related]
11. Severe and life-threatening onset of systemic lupus erythematosus.
Martins A; Pimenta S; Oliveira D; Martins F; Samões B; Costa L
Reumatol Clin (Engl Ed); 2023; 19(7):402-403. PubMed ID: 37661117
[TBL] [Abstract][Full Text] [Related]
12. Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome - Successful use of PET- CT and Anakinra in its diagnosis and treatment.
Tayer-Shifman OE; Ben-Chetrit E
Mod Rheumatol; 2015; 25(6):954-7. PubMed ID: 24252009
[TBL] [Abstract][Full Text] [Related]
13. Kikuchi-Fujimoto disease as the initial manifestation of systemic lupus erythematosus complicated with macrophage activation syndrome: two case reports and a review of literature.
Liu C; Jin Y; Huang H; Ding F; Yang Z; Xu X; Bao S; Ma J; Jin Y
BMC Pediatr; 2022 Nov; 22(1):673. PubMed ID: 36414954
[TBL] [Abstract][Full Text] [Related]
14. Acute respiratory distress syndrome associated with macrophage activation syndrome in systemic lupus erythematosus: A case report and literature review.
Chang ES; Yu HH; Wu CE; Chan TM
Medicine (Baltimore); 2022 Feb; 101(5):e28612. PubMed ID: 35119005
[TBL] [Abstract][Full Text] [Related]
15. Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
Junga Z; Stitt R; Tracy C; Keith M
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28827301
[TBL] [Abstract][Full Text] [Related]
16. Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review.
Lin Q; Zhang M; Tang H; Shen Y; Zhu Y; Xu Q; Li X
Rheumatol Int; 2020 May; 40(5):811-819. PubMed ID: 31377830
[TBL] [Abstract][Full Text] [Related]
17. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
18. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
Jiang N; Li MT; Wu D; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
[No Abstract] [Full Text] [Related]
19. Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).
Kübler L; Bittmann I; Kuipers JG
Z Rheumatol; 2020 Dec; 79(10):1040-1045. PubMed ID: 32804304
[TBL] [Abstract][Full Text] [Related]
20. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review.
Vilaiyuk S; Sirachainan N; Wanitkun S; Pirojsakul K; Vaewpanich J
Clin Rheumatol; 2013 Jun; 32(6):899-904. PubMed ID: 23483294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
